"KILLER" CELLS IN EBOLA IMMUNITY STUDY COULD HELP COVID RESEARCH

Ebola survivors showing no antibodies found to still have lasting capacity to fight virus. Immunity from the deadly Ebola virus could last years after the infection, the world’s longest study of survivors by British and Guinean scientists has concluded in findings that could have implications for Covid immunity research.

The findings are the result of the world’s longest and most comprehensive study of survivors from the devastating west African outbreak between 2013 and 2016. They could help the understanding of the body’s immune response to Covid and other zoonotic diseases. Read more HERE.